Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a weekly shot help dialysis patients manage diabetes?

NCT ID NCT06042153

First seen Jan 16, 2026 · Last updated May 25, 2026 · Updated 20 times

Summary

This study tests whether the drug semaglutide helps control blood sugar in people with type 2 diabetes who are on dialysis. About 43 participants will be randomly assigned to receive either semaglutide or a placebo injection once a week for about a year. They will wear a continuous glucose monitor for 10-day periods to track blood sugar levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • DaVita UT Southwestern - East Dallas

    Dallas, Texas, 75228, United States

  • DaVita UT Southwestern - Irving

    Irving, Texas, 75062, United States

  • DaVita UT Southwestern - Preston

    Dallas, Texas, 75240, United States

  • Davita UT Southwestern - Oak Cliff

    Dallas, Texas, 75224, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

Conditions

Explore the condition pages connected to this study.